Milnacipran is a serotonin norepinephrine reuptake inhibitor (SNRI), indicated for depression primarily.
Dose: 12.5-100 mg
Route: Oral
Plasma Half-life: 8 hours
Duration of action: N/A
Bioavailability: 85%
Chemical formula: C15H22N2O
IUPAC name: (±)-(1R,2S)-rel-2-(Aminomethyl)-N,N-diethyl-1- phenylcyclopropane-1-carboxamide
Trade name: Ixel, Savella, Dalcipran, Toledomin, Joncia
Therapeutic uses:
Milnacipran is primarily indicated for treating depression & fibromyalgia.
Side effects:
Although the SNRIs are considered to have fewer and less severe adverse effects than the TCAs, the SNRIs are not without adverse effects; Milnacipran may provoke following side effects:
- Gastrointestinal (GI) effects (nausea, vomiting, dry mouth constipation),
- Dizziness,
- Anxiety,
- Agitation,
- Headache,
- Sweating,
- Sexual dysfunction including loss of libido, delayed ejaculation, and anorgasmia
- Sleep disturbances (insomnia & somnolence)
Contraindications:
For detailed query or in case of uncertainty, Always consult your doctor or pharmacist.